Current insights on the biology and clinical aspects of VEGF regulation. - Wikidata - wikimedia - TriplyDB

Current insights on the biology and clinical aspects of VEGF regulation.

Current insights on the biology and clinical aspects of VEGF regulation.

http://www.wikidata.org/entity/Q37272329

about

Molecular mechanisms of lymphatic metastasis in solid tumors of the gastrointestinal tract ZFP36L1 is regulated by growth factors and cytokines in keratinocytes and influences their VEGF production Cochlear pericyte responses to acoustic trauma and the involvement of hypoxia-inducible factor-1alpha and vascular endothelial growth factor.Murine neural stem/progenitor cells protect neurons against ischemia by HIF-1alpha-regulated VEGF signaling Cigarette smoke and α,β-unsaturated aldehydes elicit VEGF release through the p38 MAPK pathway in human airway smooth muscle cells and lung fibroblasts.Vascular endothelial growth factor promotes the expression of cyclooxygenase 2 and matrix metalloproteinases in Lewis lung carcinoma cells Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension Vascular endothelial growth factor in children with thalassemia major.Disulfiram deregulates HIF-α subunits and blunts tumor adaptation to hypoxia in hepatoma cells Trials of bevacizumab in breast cancer--a safety review.Blocking the interaction of vascular endothelial growth factor receptors with their ligands and their effector signaling as a novel therapeutic target for cancer: time for a new look?Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy.Retinal oxygen: from animals to humans.The synergistic regulation of VEGF-mediated angiogenesis through miR-190 and target genes Linking oxygen to time: the bidirectional interaction between the hypoxic signaling pathway and the circadian clock.Red ginseng deregulates hypoxia-induced genes by dissociating the HIF-1 dimer.AAMP Regulates Endothelial Cell Migration and Angiogenesis Through RhoA/Rho Kinase Signaling.Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia.Calcium-alginate hydrogel-encapsulated fibroblasts provide sustained release of vascular endothelial growth factor Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease.The impact of high density receptor clusters on VEGF signaling.Evidences supporting the vascular etiology of post-double balloon enteroscopy pancreatitis: Study in porcine model.Cardiac myocyte p38α kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart.Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.TNF-α and LPS activate angiogenesis via VEGF and SIRT1 signalling in human dental pulp cells.Serum angiogenin level in sickle cell disease and beta thalassemia patients.VEGF is indirectly associated with NO production and acutely increases in response to hyperglycaemia(1).New vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential.

P2860

Q27013620-BEF2EA69-8EFC-4441-812E-0D041F124590 Q28115802-D98FA071-1088-4992-A23E-CEECDC7DE0A9 Q30485540-C42F6ABC-B58C-478B-945C-3365138E49BD Q33546371-CE3CD619-FFDA-49FB-B988-BF3CD2C715B4 Q35005709-DD35D4FC-017A-4205-BEE7-493F156B29AA Q36386639-0D2AB512-1DCA-4DE5-BF20-1E1DB44539A0 Q36678295-CC2EC2BB-AB33-4B8E-96C6-7A95D9F201B2 Q36934194-A15FD853-D7CF-41A0-8542-1F3437A0029F Q37729564-1C7E2C16-14FF-4DA9-82EE-1F37985550B0 Q37887823-1782E790-BF14-4380-B1F8-35C37495D1EE Q37921797-EB1BDC42-7330-49AB-9CA6-07AF5E116E1D Q38002923-343C9696-0376-4CD8-A94F-C9741CF59E8B Q38767522-CB2A594D-F6EA-4AB2-B95A-52E637DB391F Q38981547-DF9A10BD-EB80-42A9-9EB2-D5CC35CC1A74 Q39192021-1C9C38F0-2671-415C-938C-D8EF416E69E7 Q39607043-07437AFD-94E8-4AEF-89AF-11BC0876E6CB Q40561535-722042A7-1574-41E3-8F84-F6B40422E60F Q40588724-A72B3D3D-A370-4D8F-BC79-C060331324DA Q41538962-8AB875D8-E7DF-418B-BBBA-A0E700A062F7 Q41573646-5E3E3F2C-BCE7-4A75-B5BA-0DD8E87465DB Q41691387-71D168B5-47E3-4C91-ADD9-2EDC3F95626D Q42037739-767F404B-8348-4608-8D00-573D6F8E683A Q43462207-B84E4053-C95E-49D1-9A77-FD91C3239866 Q44614511-A89F9F87-486F-41DA-B6BF-147036024D72 Q46621277-B79E5AE6-08D9-4CC4-8A8F-27CA242FAD65 Q46857992-657800F1-F6A8-4BCD-B82D-1C568C997FE7 Q51357183-4ABED8D6-89DA-4AD3-B801-60AE4F4A4085 Q54624593-A638E727-998B-4FE3-A77A-3A5D3E7047A7

P2860

Current insights on the biology and clinical aspects of VEGF regulation.

http://www.wikidata.org/entity/Q37272329

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 September 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Current insights on the biology and clinical aspects of VEGF regulation.

@en

Current insights on the biology and clinical aspects of VEGF regulation.

@nl

type

label

Current insights on the biology and clinical aspects of VEGF regulation.

@en

Current insights on the biology and clinical aspects of VEGF regulation.

@nl

prefLabel

Current insights on the biology and clinical aspects of VEGF regulation.

@en

Current insights on the biology and clinical aspects of VEGF regulation.

@nl

P1433

Q37272329-7C4F7666-FE1A-4284-8495-36EC4D1AF0DA

P1476

Q37272329-76ABCE3C-7221-4DC5-AE85-89B4B4D66E79

P2093

Q37272329-32F8C6AC-4151-4B6E-B584-5C160DCB07CE

Q37272329-4BBBFC78-9F05-438A-B98B-E7271A75625B

Q37272329-6A64A80A-B685-4E97-83EE-6A2550DE94E7

Q37272329-9B579427-9FEF-459D-BAF3-E410ABF7EB98

P2860

Q37272329-000B9AE5-8491-42F5-B832-EC59F9E04439

Q37272329-00BF7598-92F2-4EC1-AEAD-2F31369E92D4

Q37272329-071997DE-FD8B-4E93-A275-8FE6FD3E2D92

Q37272329-0873D194-18A3-4EDC-8457-EC642D42934A

Q37272329-0C355C22-6FCA-443B-8A41-CEBCD605530B

Q37272329-10CEA6A0-1664-4875-90C3-136183FB054D

Q37272329-118D97DE-3839-4333-8967-7F1828096EF3

Q37272329-11F18A42-2030-4B58-B5E7-BF2A5EA5A27C

Q37272329-12E31660-9E0E-4777-93C4-D150522CD43A

Q37272329-1357E9BD-4093-4107-964A-3485F5909447

P304

Q37272329-452802C5-0695-4257-850A-9C54E9A7293E

P31

Q37272329-65A823ED-109E-48A3-AE07-49B5CC0E0906

Q37272329-81972b52-4dcc-4507-acfe-de67b91f1099

P356

Q37272329-06F9649B-A1D5-4017-893A-94434F2438C8

P433

Q37272329-7BF0DA53-FCD8-4E11-9A8B-C834D4A02BE2

P478

Q37272329-A90C8C74-2914-4500-B7FC-52BF26D51790

P577

Q37272329-0C74A3B1-198C-421F-908F-1F560589963F

P698

Q37272329-24B4BBD9-0F70-47B0-B088-4E35CE95592D

P356

1538574408322755

P1433

Vascular and Endovascular Surgery

P1476

Current insights on the biology and clinical aspects of VEGF regulation.

@en

P2093

Daniel M Birk

http://www.w3.org/2001/XMLSchema#string

Joel Barbato

http://www.w3.org/2001/XMLSchema#string

Leila Mureebe

http://www.w3.org/2001/XMLSchema#string

Rabih A Chaer

http://www.w3.org/2001/XMLSchema#string

P2860

Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes

Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

Two independent internal ribosome entry sites are involved in translation initiation of vascular endothelial growth factor mRNA

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1

Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers

P304

517-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1538574408322755

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18799497

http://www.w3.org/2001/XMLSchema#string